No connection

Search Results

AMS vs XWEL

AMS
American Shared Hospital Services
BEARISH
Price
$1.33
Market Cap
$8.8M
Sector
Healthcare
AI Confidence
95%
XWEL
XWELL, Inc.
BEARISH
Price
$1.14
Market Cap
$9.0M
Sector
Healthcare
AI Confidence
95%

Valuation

P/E Ratio
AMS
--
XWEL
--
Forward P/E
AMS
3.34
XWEL
-0.43
P/B Ratio
AMS
0.37
XWEL
-1.04
P/S Ratio
AMS
0.31
XWEL
0.31
EV/EBITDA
AMS
8.29
XWEL
-3.37

Profitability

Gross Margin
AMS
38.31%
XWEL
25.7%
Operating Margin
AMS
-13.98%
XWEL
-45.07%
Profit Margin
AMS
-5.53%
XWEL
-58.17%
ROE
AMS
-9.45%
XWEL
--
ROA
AMS
-2.18%
XWEL
-31.98%

Growth

Revenue Growth
AMS
-14.8%
XWEL
-4.2%
Earnings Growth
AMS
--
XWEL
--

Financial Health

Debt/Equity
AMS
0.78
XWEL
--
Current Ratio
AMS
0.76
XWEL
0.46
Quick Ratio
AMS
0.71
XWEL
0.33

Dividends

Dividend Yield
AMS
--
XWEL
--
Payout Ratio
AMS
0.0%
XWEL
0.0%

AI Verdict

AMS BEARISH

AMS exhibits severe financial distress, anchored by a weak Piotroski F-Score of 2/9 and a critical liquidity position with a current ratio of 0.76. The company is experiencing a systemic decline, evidenced by a -14.80% YoY revenue contraction and a disastrous -200% YoY EPS growth. Despite a low Price-to-Book ratio of 0.37, the stock is in a technical freefall (0/100 trend) and consistently misses earnings estimates by wide margins. The combination of negative profitability and shrinking top-line growth suggests a value trap rather than a value opportunity.

Strengths
Positive Gross Margin (38.31%)
Low Price-to-Book ratio (0.37)
Low Price-to-Sales ratio (0.31)
Risks
Severe liquidity risk (Current Ratio 0.76 < 1.0)
Negative revenue growth (-14.80% YoY)
Consistent and massive earnings misses (Recent surprise -550%)
XWEL BEARISH

XWEL exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price-to-Book ratio of -1.04, indicating negative shareholder equity. The company is facing a liquidity crisis with a Current Ratio of 0.46 and a Quick Ratio of 0.33, suggesting it cannot meet its short-term obligations. While there has been a speculative 1-year price recovery and recent EPS 'beats,' these are relative to deeply negative expectations and do not offset the fundamental insolvency risks. The combination of declining revenue (-4.20% YoY) and negative margins makes the current valuation unsustainable.

Strengths
Low Price-to-Sales ratio (0.31) suggests the market has already priced in significant failure
Recent quarterly EPS surprises have been positive (beating negative estimates)
Short-term 1-year price performance shows speculative interest (+48%)
Risks
Extreme bankruptcy risk indicated by Piotroski F-Score of 1/9
Negative equity (P/B -1.04) indicates liabilities exceed assets
Severe liquidity shortage with a Current Ratio well below 1.0 (0.46)

Compare Another Pair

AMS vs XWEL: Head-to-Head Comparison

This page compares American Shared Hospital Services (AMS) and XWELL, Inc. (XWEL) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile